Rainer Müller
Impact in
- Pharmaceutical Science top 0.01%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 0.02%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 106
- Advanced Drug Delivery Systems 54
- Drug Solubulity and Delivery Systems 53
-
- Lipid Membrane Structure and Behavior 51
- Protein purification and stability 29
- Co-authors
- S. A. Wissing (19 shared papers)Cornelia M. Keck (44 shared papers)Eliana B. Souto (24 shared papers)Oliver Kayser (11 shared papers)Matthias Radtke (3 shared papers)Claudia Jacobs (3 shared papers)Ranjita Shegokar (16 shared papers)Jana Pardeike (7 shared papers)
- Journals
- International Journal of Pharmaceutics (68 papers)European Journal of Pharmaceutics and Biopharmaceutics (32 papers)Journal of Controlled Release (15 papers)European Journal of Pharmaceutical Sciences (13 papers)Journal of drug targeting (9 papers)
- Partner nations
- GermanyItalyUnited States
In The Last Decade
Rainer Müller
349 papers receiving 31.1k citations
Rainer Müller's Hit Papers
Peers
Comparison fields: 5 of 203
- Pharmaceutical Science 17.1k
- Biomaterials 7.1k
- Dermatology 2.5k
- Food Science 5.5k
- Molecular Medicine 989
Countries citing papers authored by Rainer Müller
This map shows the geographic impact of Rainer Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Müller more than expected).
Fields of papers citing papers by Rainer Müller
This network shows the impact of papers produced by Rainer Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Müller. The network helps show where Rainer Müller may publish in the future.
Co-authors
The 25 scholars most cited alongside Rainer Müller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 368 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Hit paper breakdown → | 2002 | 1644 |
| 2 | ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Hit paper breakdown → | 2000 | 1430 |
| 3 | Nanosuspensions as particulate drug formulations in therapy Hit paper breakdown → | 2001 | 1153 |
| 4 | Solid lipid nanoparticles for parenteral drug delivery Hit paper breakdown → | 2004 | 1106 |
| 5 | Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Hit paper breakdown → | 2008 | 1075 |
| 6 | Nanostructured lipid matrices for improved microencapsulation of drugs Hit paper breakdown → | 2002 | 932 |
| 7 | Nanocrystal technology, drug delivery and clinical applications Hit paper breakdown → | 2008 | 744 |
| 8 | The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres Hit paper breakdown → | 1995 | 669 |
| 9 | Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles Hit paper breakdown → | 2004 | 596 |
| 10 | Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions Hit paper breakdown → | 1998 | 577 |
| 11 | Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives Hit paper breakdown → | 2010 | 556 |
| 12 | Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Hit paper breakdown → | 2004 | 549 |
| 13 | State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular delivery Hit paper breakdown → | 2011 | 539 |
| 14 | 1994 | 453 | |
| 15 | 2011 | 422 | |
| 16 | 2013 | 419 | |
| 17 | 1999 | 401 | |
| 18 | 2002 | 360 | |
| 19 | 2008 | 337 | |
| 20 | 2002 | 326 |
About Rainer Müller
Rainer Müller is a scholar working on Pharmaceutical Science, Molecular Biology, Food Science, Industrial and Manufacturing Engineering and Dermatology, having authored 368 papers that have together received 32.4k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (106 papers), Advanced Drug Delivery Systems (54 papers), Drug Solubulity and Delivery Systems (53 papers), Lipid Membrane Structure and Behavior (51 papers), Flexible and Reconfigurable Manufacturing Systems (42 papers), Manufacturing Process and Optimization (38 papers), Protein purification and stability (29 papers) and Bee Products Chemical Analysis (28 papers). The work is most often cited by research in Pharmaceutical Science (17.1k citations), Biomaterials (7.1k citations), Dermatology (2.5k citations), Food Science (5.5k citations) and Molecular Medicine (989 citations). Rainer Müller has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include S. A. Wissing, Cornelia M. Keck, Eliana B. Souto, Oliver Kayser, Matthias Radtke, Claudia Jacobs, Ranjita Shegokar, Jana Pardeike, A. Hommoss and Jan P. Möschwitzer. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Controlled Release, European Journal of Pharmaceutical Sciences and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.